Publications from OUS - Neuro-oncology research group

72 publications found

1. Heggebø LC, Blakstad H, Eriksson MC, Brandal P (2024)
   Lomustine overdose in a patient with diffuse glioma: symptoms, management and outcome
   BMJ Case Rep, 17 (7)
   DOI 10.1136/bcr-2024-260450, PubMed 39043464
2. Prysiazhniuk Y, Server A, Leske H, Bech-Aase Ø, Helseth E, Eijgelaar RS, Fuster-García E, Brandal P, Bjørnerud A, Otáhal J, Petr J, Nordhøy W (2024)
   Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study
   Neurooncol Adv, 6 (1), vdae113
   DOI 10.1093/noajnl/vdae113, PubMed 39036439
3. Felip E, Metro G, Soo RA, Wolf J, Solomon BJ, Tan DS, Ardizzoni A, Lee DH, Sequist LV, Barlesi F, Ponce-Aix S, Abreu DR, Campelo MRG, Sprauten M, Djentuh LO, Smith N, Jary A, Belli R, Glaser S, Zou M, Cui X, Giovannini M, Yang JC (2024)
   Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
   Eur J Cancer, 208, 114182 (in press)
   DOI 10.1016/j.ejca.2024.114182, PubMed 38986421
4. Halldorsson S, Nagymihaly RM, Patel A, Brandal P, Panagopoulos I, Leske H, Lund-Iversen M, Sahm F, Vik-Mo EO (2024)
   Accurate and comprehensive evaluation of O6-methylguanine-DNA methyltransferase promoter methylation by nanopore sequencing
   Neuropathol Appl Neurobiol, 50 (3), e12984
   DOI 10.1111/nan.12984, PubMed 38783575
5. Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
   The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
   J Neurooncol, 169 (1), 137-145
   DOI 10.1007/s11060-024-04709-z, PubMed 38762830
6. Tauziède-Espariat A, Nicaise Y, Sievers P, Sahm F, von Deimling A, Guillemot D, Pierron G, Duchesne M, Edjlali M, Dangouloff-Ros V, Boddaert N, Roux A, Dezamis E, Hasty L, Lhermitte B, Hirsch E, Hirsch MPV, Ardellier FD, Karnoub MA, Csanyi M, Maurage CA, Mokhtari K, Bielle F, Rigau V, Roujeau T et al. (2024)
   CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
   Acta Neuropathol Commun, 12 (1), 55
   DOI 10.1186/s40478-023-01695-7, PubMed 38581034
7. Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M (2024)
   3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
   Neuro Oncol, 26 (7), 1302-1309
   DOI 10.1093/neuonc/noae037, PubMed 38452246
8. Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
   Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
   Neurooncol Pract, 11 (1), 36-45
   DOI 10.1093/nop/npad063, PubMed 38222046
9. Mendoza Mireles EE, Skaga E, Server A, Leske H, Brandal P, Helseth E, Rønning PA, Vik-Mo EO (2023)
   The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study
   Neurooncol Pract, 10 (6), 555-564
   DOI 10.1093/nop/npad037, PubMed 38026582
10. Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
    Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
    BMJ Open, 13 (3), e070071
    DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
11. Leske H, Blakstad H, Lund-Iversen M, Skovholt EK, Niehusmann P, Ramm-Pettersen JT, Skogen K, Kongelf G, Sprauten M, Magelssen H, Brandal P (2023)
    Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A
    Neuropathology, 43 (5), 385-390
    DOI 10.1111/neup.12895, PubMed 36754566
12. Blakstad H, Brekke J, Rahman MA, Arnesen VS, Miletic H, Brandal P, Lie SA, Chekenya M, Goplen D (2023)
    Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
    PLoS One, 18 (2), e0281166
    DOI 10.1371/journal.pone.0281166, PubMed 36730349
13. Schipmann-Miletic S, Sivakanesan S, Rath DS, Brandal P, Vik-Mo E, Bjørås M, Solheim O, Ingebrigtsen T, Sund F, Bjerkvig R, Miletic H, Johannessen TA, Sundstrøm T (2023)
    [Glioblastoma in adults]
    Tidsskr Nor Laegeforen, 143 (2)
    DOI 10.4045/tidsskr.22.0314, PubMed 36718891
14. Tanem KE, Stensvold E, Wilberg P, Skaare AB, Brandal P, Herlofson BB (2022)
    Oral and dental late effects in long-term survivors of childhood embryonal brain tumors
    Support Care Cancer, 30 (12), 10233-10241
    DOI 10.1007/s00520-022-07405-8, PubMed 36307656
15. Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2022)
    Idiopathic Duro-Optic Calcification
    J Neuroophthalmol, 44 (1), e204
    DOI 10.1097/WNO.0000000000001722, PubMed 36255093
16. Blakstad H, Wohlleben C, Saxhaug C, Brandal P (2022)
    SMART syndrome: two cases highlighting a complex and rare complication of brain irradiation
    BMJ Case Rep, 15 (9)
    DOI 10.1136/bcr-2022-249599, PubMed 36167430
17. Kvammen JA, Stensvold E, Godang K, Bollerslev J, Myklebust TÅ, Brandal P, Henriksen C, Bechensteen AG (2022)
    Bone mineral density and nutrition in long-term survivors of childhood brain tumors
    Clin Nutr ESPEN, 50, 162-169
    DOI 10.1016/j.clnesp.2022.05.025, PubMed 35871919
18. Niehusmann P, Stensvold E, Leske H, Pietsch T, Goschzik T, Gielen GH, Due-Tønnessen B, Frič R, Nilssen Y, Brandal P (2022)
    Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017
    Pediatr Blood Cancer, 69 (9), e29736
    DOI 10.1002/pbc.29736, PubMed 35570402
19. Tanem KE, Stensvold E, Wilberg P, Skaare AB, Singh PB, Brandal P, Herlofson BB (2022)
    Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
    Support Care Cancer, 30 (7), 6155-6162
    DOI 10.1007/s00520-022-07048-9, PubMed 35426047
20. Hauger SL, Borgen IMH, Løvstad M, Lu J, Forslund MV, Kleffelgård I, Andelic N, Røe C (2022)
    Community-Based Interventions After Acquired Brain Injury-A Systematic Review of Intervention Types and Their Effectiveness
    J Head Trauma Rehabil, 37 (5), E355-E369
    DOI 10.1097/HTR.0000000000000765, PubMed 35125426
21. Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM et al. (2021)
    Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
    Acta Oncol, 61 (2), 235-238
    DOI 10.1080/0284186X.2021.2022202, PubMed 34970940
22. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Due-Tønnessen P (2021)
    Choroid Plexus Tumors in Children: Long-Term Follow-Up of Consecutive Single-Institutional Series of 59 Patients Treated over a Period of 8 Decades (1939-2020)
    World Neurosurg, 158, e810-e819
    DOI 10.1016/j.wneu.2021.11.070, PubMed 34823041
23. Borgen IMH, Kleffelgård I, Hauger SL, Forslund MV, Søberg HL, Andelic N, Sveen U, Winter L, Løvstad M, Røe C (2021)
    Patient-Reported Problem Areas in Chronic Traumatic Brain Injury
    J Head Trauma Rehabil, 37 (5), E336-E345
    DOI 10.1097/HTR.0000000000000744, PubMed 34743086
24. Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville-Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balaná C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J et al. (2022)
    Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
    Neuro Oncol, 24 (5), 755-767
    DOI 10.1093/neuonc/noab243, PubMed 34672349
25. Switlyk MD, Niehusmann P, Sprauten M, Magelssen H, Aarhus M, Rasmussen FØ, Knutstad K, Brandal P (2021)
    Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge
    Acta Radiol Open, 10 (7), 20584601211036550
    DOI 10.1177/20584601211036550, PubMed 34377543
26. Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
    Outcome after treatment of pediatric supratentorial ependymoma: long-term follow-up of a single consecutive institutional series of 26 patients
    Br J Neurosurg, 38 (2), 514-522
    DOI 10.1080/02688697.2021.1914821, PubMed 34096810
27. Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2021)
    Bilateral calcification of the optic nerve sheath: A diagnostic dilemma
    Am J Ophthalmol Case Rep, 22, 101106
    DOI 10.1016/j.ajoc.2021.101106, PubMed 33997471
28. Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
    Outcome After Treatment of Spinal Ependymoma in Children and Adolescents: Long-Term Follow-up of a Single Consecutive Institutional Series of 33 Patients Treated Over Eight Decades
    World Neurosurg, 150, e228-e235
    DOI 10.1016/j.wneu.2021.02.131, PubMed 33684583
29. Skaga E, Skretteberg MA, Johannesen TB, Brandal P, Vik-Mo EO, Helseth E, Langmoen IA (2021)
    Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
    Neurooncol Adv, 3 (1), vdab008
    DOI 10.1093/noajnl/vdab008, PubMed 33665615
30. Brandal P, Bergfeldt K, Aggerholm-Pedersen N, Bäckström G, Kerna I, Gubanski M, Björnlinger K, Evensen ME, Kuddu M, Pettersson E, Brydøy M, Hellebust TP, Dale E, Valdman A, Weber L, Høyer M (2020)
    A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients
    Acta Oncol, 59 (10), 1157-1163
    DOI 10.1080/0284186X.2020.1817977, PubMed 32902341
31. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2020)
    Outcomes in adulthood after neurosurgical treatment of brain tumors in the first 3 years of life: long-term follow-up of a single consecutive institutional series of 97 patients
    Childs Nerv Syst, 37 (2), 427-433
    DOI 10.1007/s00381-020-04859-1, PubMed 32814984
32. Stadskleiv K, Stensvold E, Stokka K, Bechensteen AG, Brandal P (2020)
    Neuropsychological functioning in survivors of childhood medulloblastoma/CNS-PNET: The role of secondary medical complications
    Clin Neuropsychol, 36 (3), 600-625
    DOI 10.1080/13854046.2020.1794045, PubMed 32729777
33. Rahman MA, Brekke J, Arnesen V, Hannisdal MH, Navarro AG, Waha A, Herfindal L, Rygh CB, Bratland E, Brandal P, Haasz J, Oltedal L, Miletic H, Lundervold A, Lie SA, Goplen D, Chekenya M (2020)
    Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study
    Immun Inflamm Dis, 8 (3), 342-359
    DOI 10.1002/iid3.315, PubMed 32578964
34. Kierulf-Vieira KS, Sandberg CJ, Waaler J, Lund K, Skaga E, Saberniak BM, Panagopoulos I, Brandal P, Krauss S, Langmoen IA, Vik-Mo EO (2020)
    A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
    Cancers (Basel), 12 (6)
    DOI 10.3390/cancers12061630, PubMed 32575464
35. Frič R, Due-Tønnessen BJ, Lundar T, Egge A, Kronen Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2020)
    Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood
    Sci Rep, 10 (1), 9371
    DOI 10.1038/s41598-020-66328-8, PubMed 32523021
36. Clarke M, Mackay A, Ismer B, Pickles JC, Tatevossian RG, Newman S, Bale TA, Stoler I, Izquierdo E, Temelso S, Carvalho DM, Molinari V, Burford A, Howell L, Virasami A, Fairchild AR, Avery A, Chalker J, Kristiansen M, Haupfear K, Dalton JD, Orisme W, Wen J, Hubank M, Kurian KM et al. (2020)
    Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
    Cancer Discov, 10 (7), 942-963
    DOI 10.1158/2159-8290.CD-19-1030, PubMed 32238360
37. Jeanmougin M, Håvik AB, Cekaite L, Brandal P, Sveen A, Meling TR, Ågesen TH, Scheie D, Heim S, Lothe RA, Lind GE (2020)
    Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment
    Mol Oncol, 14 (5), 1016-1027
    DOI 10.1002/1878-0261.12668, PubMed 32171051
38. Larsson C, Groote I, Vardal J, Kleppestø M, Odland A, Brandal P, Due-Tønnessen P, Holme SS, Hope TR, Meling TR, Fosse E, Emblem KE, Bjørnerud A (2020)
    Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy
    Magn Reson Imaging, 68, 106-112
    DOI 10.1016/j.mri.2020.01.012, PubMed 32004711
39. Stensvold E, Stadskleiv K, Myklebust TÅ, Wesenberg F, Helseth E, Bechensteen AG, Brandal P (2020)
    Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors
    Acta Paediatr, 109 (9), 1875-1886
    DOI 10.1111/apa.15188, PubMed 31977119
40. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
    Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
    Acta Oncol, 58 (10), 1416-1422
    DOI 10.1080/0284186X.2019.1643496, PubMed 31364899
41. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2019)
    Adult outcome after neurosurgical treatment of brain tumours in the first year of life: long-term follow-up of a single consecutive institutional series of 34 patients
    Acta Neurochir (Wien), 161 (9), 1793-1798
    DOI 10.1007/s00701-019-04014-z, PubMed 31309304
42. Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019)
    18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
    Clin Nucl Med, 44 (8), 605-611
    DOI 10.1097/RLU.0000000000002641, PubMed 31274605
43. Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P (2019)
    Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival
    Pediatr Blood Cancer, 66 (10), e27910
    DOI 10.1002/pbc.27910, PubMed 31264356
44. Latysheva A, Emblem KE, Brandal P, Vik-Mo EO, Pahnke J, Røysland K, Hald JK, Server A (2019)
    Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach
    Neuroradiology, 61 (5), 545-555
    DOI 10.1007/s00234-019-02173-5, PubMed 30712139
45. Johannessen LE, Brandal P, Myklebust TÅ, Heim S, Micci F, Panagopoulos I (2018)
    MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas
    Cancer Genomics Proteomics, 15 (6), 437-446
    DOI 10.21873/cgp.20102, PubMed 30343277
46. Panagopoulos I, Gorunova L, Leske H, Niehusmann P, Johannessen LE, Staurseth J, Øino N, Meling TR, Heim S, Micci F, Brandal P (2018)
    Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma
    Cancer Genomics Proteomics, 15 (5), 379-385
    DOI 10.21873/cgp.20096, PubMed 30194078
47. Lundar T, Due-Tønnessen BJ, Fric R, Egge A, Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2018)
    Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients
    Acta Neurochir (Wien), 160 (6), 1207-1214
    DOI 10.1007/s00701-018-3550-8, PubMed 29680921
48. Leske H, Brandal P, Rushing EJ, Niehusmann P (2017)
    IDH-mutant giant cell glioblastoma: A neglected tumor variant?
    Clin Neuropathol, 36 (6), 293-295
    DOI 10.5414/NP301054, PubMed 29035191
49. Stensvold E, Krossnes BK, Lundar T, Due-Tønnessen BJ, Frič R, Due-Tønnessen P, Bechensteen AG, Myklebust TÅ, Johannesen TB, Brandal P (2017)
    Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment
    Acta Oncol, 56 (5), 698-705
    DOI 10.1080/0284186X.2017.1301679, PubMed 28325133
50. Olsen TK, Panagopoulos I, Gorunova L, Micci F, Andersen K, Kilen Andersen H, Meling TR, Due-Tønnessen B, Scheie D, Heim S, Brandal P (2016)
    Novel fusion genes and chimeric transcripts in ependymal tumors
    Genes Chromosomes Cancer, 55 (12), 944-953
    DOI 10.1002/gcc.22392, PubMed 27401149
51. Varghese M, Nymoen HG, Saxhaug C, Krossnes B, Abdol Mohieb Hosainey S, Meling TR, Brandal P (2016)
    Symptomatic spinal metastasis from intracranial glioblastoma multiforme - Two illustrative cases and a review of the literature
    Acta Oncol, 55 (9-10), 1236-1238
    DOI 10.3109/0284186X.2016.1161824, PubMed 27174685
52. Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P (2016)
    Persistent bone marrow depression following short-term treatment with temozolomide
    BMJ Case Rep, 2016
    DOI 10.1136/bcr-2016-215797, PubMed 27130558
53. Due-Tønnessen BJ, Egge A, Lundar T, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
    Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy
    Springerplus, 4, 389
    DOI 10.1186/s40064-015-1178-1, PubMed 26251773
54. Lundar T, Due-Tønnessen BJ, Egge A, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
    Neurosurgical treatment of brain tumors in the first 6 months of life: long-term follow-up of a single consecutive institutional series of 30 patients
    Childs Nerv Syst, 31 (12), 2283-90
    DOI 10.1007/s00381-015-2792-5, PubMed 26174616
55. Olsen TK, Panagopoulos I, Meling TR, Micci F, Gorunova L, Thorsen J, Due-Tønnessen B, Scheie D, Lund-Iversen M, Krossnes B, Saxhaug C, Heim S, Brandal P (2015)
    Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
    Neuro Oncol, 17 (10), 1365-73
    DOI 10.1093/neuonc/nov039, PubMed 25795305
56. Lundar T, Due-Tønnessen BJ, Egge A, Scheie D, Brandal P, Stensvold E, Due-Tønnessen P (2014)
    Neurosurgical treatment of pediatric low-grade midbrain tumors: a single consecutive institutional series of 15 patients
    J Neurosurg Pediatr, 14 (6), 598-603
    DOI 10.3171/2014.9.PEDS1462, PubMed 25325421
57. Lundar T, Due-Tønnessen BJ, Scheie D, Brandal P (2014)
    Pediatric spinal ependymomas: an unpredictable and puzzling disease. Long-term follow-up of a single consecutive institutional series of ten patients
    Childs Nerv Syst, 30 (12), 2083-8
    DOI 10.1007/s00381-014-2491-7, PubMed 25079883
58. Rogne SG, Helseth E, Brandal P, Scheie D, Meling TR (2013)
    Are melanomas averse to cerebellum? Cerebellar metastases in a surgical series
    Acta Neurol Scand, 130 (1), 1-10
    DOI 10.1111/ane.12206, PubMed 24313862
59. Håvik AB, Lind GE, Honne H, Meling TR, Scheie D, Hall KS, van den Berg E, Mertens F, Picci P, Lothe RA, Heim S, Brandal P (2013)
    Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors
    Neuro Oncol, 16 (2), 320-2
    DOI 10.1093/neuonc/not230, PubMed 24311631
60. Lundar T, Due-Tønnessen BJ, Egge A, Scheie D, Stensvold E, Brandal P (2013)
    Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients
    J Neurosurg Pediatr, 12 (3), 241-6
    DOI 10.3171/2013.6.PEDS12586, PubMed 23870041
61. Waldeland E, Brustugun OT, Ramberg C, Helland Å (2012)
    [Stereotactic irradiation in spinal metastases]
    Tidsskr Nor Laegeforen, 132 (22), 2478-9
    DOI 10.4045/tidsskr.12.1108, PubMed 23338027
62. Larsson C, Kleppestø M, Rasmussen I, Salo R, Vardal J, Brandal P, Bjørnerud A (2012)
    Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results
    J Magn Reson Imaging, 37 (4), 818-29
    DOI 10.1002/jmri.23866, PubMed 23086710
63. Håvik AB, Brandal P, Honne H, Dahlback HS, Scheie D, Hektoen M, Meling TR, Helseth E, Heim S, Lothe RA, Lind GE (2012)
    MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
    J Transl Med, 10, 36
    DOI 10.1186/1479-5876-10-36, PubMed 22390413
64. Kyriazoglou AI, Dimitriadis E, Arnogiannaki N, Brandal P, Heim S, Pandis N (2011)
    Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas
    Cancer Genet, 204 (12), 677-81
    DOI 10.1016/j.cancergen.2011.10.013, PubMed 22285020
65. Dahlback HS, Brandal P, Gorunova L, Widing E, Meling TR, Krossnes BK, Heim S (2011)
    Genomic aberrations in pediatric gliomas and embryonal tumors
    Genes Chromosomes Cancer, 50 (10), 788-99
    DOI 10.1002/gcc.20898, PubMed 21717527
66. Dahlback HS, Brandal P, Krossnes BK, Fric R, Meling TR, Meza-Zepeda LA, Danielsen HE, Heim S (2011)
    Multiple chromosomal monosomies are characteristic of giant cell ependymoma
    Hum Pathol, 42 (12), 2042-6
    DOI 10.1016/j.humpath.2011.02.012, PubMed 21683982
67. Dahlback HS, Gorunova L, Micci F, Scheie D, Brandal P, Meling TR, Heim S (2011)
    Molecular cytogenetic analysis of a gliosarcoma with osseous metaplasia
    Cytogenet Genome Res, 134 (2), 88-95
    DOI 10.1159/000326804, PubMed 21555877
68. Dahlback HS, Gorunova L, Brandal P, Scheie D, Helseth E, Meling TR, Heim S (2011)
    Genomic aberrations in diffuse low-grade gliomas
    Genes Chromosomes Cancer, 50 (6), 409-20
    DOI 10.1002/gcc.20866, PubMed 21412929
69. Brandal P, Bjerkehagen B, Bruland OS, Skjeldal S, Bogsrud TV, Hall KS (2009)
    Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience
    Acta Oncol, 48 (8), 1165-72
    DOI 10.3109/02841860903032809, PubMed 19863225
70. Brandal P, Panagopoulos I, Bjerkehagen B, Heim S (2009)
    t(19;22)(q13;q12) Translocation leading to the novel fusion gene EWSR1-ZNF444 in soft tissue myoepithelial carcinoma
    Genes Chromosomes Cancer, 48 (12), 1051-6
    DOI 10.1002/gcc.20706, PubMed 19760602
71. Dahlback HS, Brandal P, Meling TR, Gorunova L, Scheie D, Heim S (2009)
    Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways
    Genes Chromosomes Cancer, 48 (10), 908-24
    DOI 10.1002/gcc.20690, PubMed 19603525
72. Brandal P, Panagopoulos I, Bjerkehagen B, Gorunova L, Skjeldal S, Micci F, Heim S (2008)
    Detection of a t(1;22)(q23;q12) translocation leading to an EWSR1-PBX1 fusion gene in a myoepithelioma
    Genes Chromosomes Cancer, 47 (7), 558-64
    DOI 10.1002/gcc.20559, PubMed 18383210